FOR more info, visit the PCSO 4D Lotto page.

在其他近期新闻中，4D分子治疗公司收到了金融分析师的一系列更新，其管线也有重大进展。Leerink Partners修订了公司的目标价，将其降至27美元，同时维持"优于大市"评级。这是在公司宣布优先发展其4D-150项目（用于湿性年龄相关性黄斑变性（wAMD）和糖尿病黄斑水肿（DME））以及4D-710项目（用于囊性纤维化（CF））之后。

Researchers have achieved remarkable progress in the field of electromagnetic metamaterials (EMMs) through 3D and 4D printing technologies. This innovation is set to revolutionize multiple industries ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $34.0, a high estimate of $46.00 ...